Kopran Limited (BSE: 524280)
Health Care · Pharmaceuticals · IN
Rs251.30
-10.97% today · +44.5% 1Y
Kopran Limited (BSE: 524280) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $125.38M.
Over the last twelve months the share price has gained 44.5%, trading between 107.00 and 295.90.
Tweenvest scores Kopran Limited across four factors: quality 72/100, value 19/100, growth 20/100, dividend 27/100. Its strongest factor is quality.
524280 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $125.38M
- Revenue (TTM)
- $74.05M
- P/E
- 48.58
- EPS
- 5.17
- Dividend yield
- 1.19%
- Beta (5Y)
- 0.89
- 52-week high
- Rs295.90
- 52-week low
- Rs107.00
- Avg volume (3M)
- —
- Shares outstanding
- 48.29M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Sunhawk Vision Biotech, Inc.TPEX: 7759 | $126.93M | NT$57.70 | +35.61% |
| JW Lifescience CorporationKOSE: A234080 | $126.01M | ₩10,940.00 | -0.82% |
| Jerusalem Pharmaceuticals Co. Ltd.PLSE: JPH | $126.00M | $3.50 | -0.85% |
| Curatis Holding AGSWX: CURN | $125.99M | CHF19.70 | +12.57% |
| Vikram Thermo (India) LimitedBSE: 530477 | $124.99M | Rs385.75 | -4.96% |
| Orient EuroPharma Co., Ltd.TPEX: 4120 | $124.80M | NT$46.00 | -0.22% |
| Semnur Pharmaceuticals, Inc.OTCPK: SMNR | $124.31M | $0.54 | +20.00% |
| T.Man Pharmaceutical Public Company LimitedSET: TMAN | $123.98M | ฿10.40 | -0.95% |
Figures last refreshed Oct 11, 2026.